4//SEC Filing
BANSAL AJAY 4
Accession 0001209191-19-055358
CIK 0001740547other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 7:45 PM ET
Size
7.4 KB
Accession
0001209191-19-055358
Insider Transaction Report
Form 4
BANSAL AJAY
PFO;CFO/Urovant Sciences, Inc.
Transactions
- Award
Common Shares
2019-11-05+75,000→ 75,000 total - Award
Stock Option (Right to Buy)
2019-11-05+140,000→ 140,000 totalExercise: $9.66Exp: 2029-11-05→ Common Shares (140,000 underlying)
Footnotes (2)
- [F1]25% of the Restricted Stock Units shall vest on October 28, 2020; the remaining Restricted Stock Units vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.
- [F2]25% of the total shares underlying the option shall vest and become exercisable on October 28, 2020; the remaining shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.
Documents
Issuer
Urovant Sciences Ltd.
CIK 0001740547
Entity typeother
Related Parties
1- filerCIK 0001236922
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 7:45 PM ET
- Size
- 7.4 KB